Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
88.54
+0.15 (0.17%)
At close: Nov 22, 2024, 4:00 PM
89.74
+1.20 (1.36%)
After-hours: Nov 22, 2024, 7:36 PM EST
Vaxcyte Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 147.5, with a low estimate of 129 and a high estimate of 163. The average target predicts an increase of 66.59% from the current stock price of 88.54.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +58.12% | Nov 6, 2024 |
| Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +84.10% | Sep 10, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $101 → $140 | Strong Buy | Maintains | $101 → $140 | +58.12% | Sep 4, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $106 → $153 | Buy | Maintains | $106 → $153 | +72.80% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.16
from -4.14
EPS Next Year
-4.80
from -4.16
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.88 | -3.89 | -2.79 | ||
| Avg | -4.16 | -4.80 | -5.28 | ||
| Low | -4.85 | -6.88 | -8.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.